Evidence map›Paper›PMID 39895823›Full record

ArticleFrontiers in medicine2024

Predictors of developing severe COVID-19 among hospitalized patients: a retrospective study.

Hussain Abduljaleel Alkhalifa, Ehab Darwish, Zaenb Alsalman, Aman Alfaraj, Abdullah Alkhars, Fatimah Alkhalifa, Mohammed Algaraash, Ahmed Mohammed Elshebiny, Emad Alkhoufi, Khaled Mohamed Amin Elzorkany

Abstract read
In one paragraph

Article in Frontiers in medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Observational
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hussain Abduljaleel AlkhalifaInternal Medicine Department, College of Medicine, King Faisal University, Al-Ahsa, Saudi Arabia.
Ehab DarwishInternal Medicine Department, College of Medicine, King Faisal University, Al-Ahsa, Saudi Arabia.
Zaenb AlsalmanFamily and Community Medicine Department, College of Medicine, King Faisal University, Al-Ahsa, Saudi Arabia.
Aman AlfarajInternal Medicine Department, King Fahad Specialist Hospital, Dammam, Saudi Arabia.
Abdullah AlkharsDepartment of Pediatric, King Fahad Medical City, Riyadh, Saudi Arabia.
Fatimah AlkhalifaPathology Department, King Fahad Specialist Hospital, Dammam, Saudi Arabia.
Mohammed AlgaraashInternal Medicine Department, Prince Saud Bin Jalawi Hospital, Al-Ahsa, Saudi Arabia.
Ahmed Mohammed ElshebinyInternal Medicine Department, College of Medicine, King Faisal University, Al-Ahsa, Saudi Arabia.
Emad AlkhoufiInternal Medicine Department, College of Medicine, King Faisal University, Al-Ahsa, Saudi Arabia.
Khaled Mohamed Amin ElzorkanyInternal Medicine Department, College of Medicine, King Faisal University, Al-Ahsa, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: COVID-19 poses a significant threat to global public health. As the severity of SARS-CoV-2 infection varies among individuals, elucidating risk factors for severe COVID-19 is important for predicting and preventing illness progression, as well as lowering case fatality rates. This work aimed to explore risk factors for developing severe COVID-19 to enhance the quality of care provided to patients and to prevent complications. Methods: A retrospective study was conducted in Saudi Arabia's eastern province, including all COVID-19 patients aged 18 years or older who were hospitalized at Prince Saud Bin Jalawi Hospital in July 2020. Comparative tests as well as both univariate and multivariate logistic regression analyses were performed to identify risk factors for developing severe COVID-19 and poor outcomes. Results: Based on the comparative statistical tests patients with severe COVID-19 were statistically significantly associated with older age and had higher respiratory rate, longer hospital stay, and higher prevalence of diabetes than non-severe cases. They also exhibited statistically significant association with high levels of potassium, urea, creatinine, lactate dehydrogenase (LDH), D-dimer, and aspartate aminotransferase (AST). The univariate analysis shows that having diabetes, having high severe acute respiratory infection chest X-ray scores, old age, prolong hospitalization, high potassium and lactate dehydrogenase, as well as using insulin, heparin, corticosteroids, favipiravir or azithromycin were all statistically significant associated with severe COVID-19. However, after adjustments in the multivariate analysis, the sole predictor was serum LDH ( Conclusion: This study sheds light on numerous parameters that may be utilized to construct a prediction model for evaluating the risk of severe COVID-19. However, no protective factors were included in this prediction model.

Indexed as

COVID-19epidemiologyoutcomerisk factorsSARS-CoV-2severe

Identifiers

PMID39895823
PMCPMC11784616

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.